Literature DB >> 10102797

The inhibitory effect of polysaccharides isolated from Phellinus linteus on tumor growth and metastasis.

S B Han1, C W Lee, Y J Jeon, N D Hong, I D Yoo, K H Yang, H M Kim.   

Abstract

It was previously reported that polysaccharides (PL) isolated from Phellinus linteus strongly stimulated cell-mediated and humoral immunity. This study was undertaken to investigate the immunochemotherapeutic activity of PL against tumor growth and metastasis. PL alone significantly prolonged the survival rate of B16F10-implanted mice, inhibited tumor growth in NCI-H23-implanted nude mice, and reduced the frequency of pulmonary metastasis of B16F10 melanoma. Adriamycin significantly inhibited tumor growth, but only slightly inhibited metastasis. The combination therapy with PL and adriamycin was more effective in inhibiting tumor growth, but not metastasis. PL did not induce direct toxicity in cancer cells, which is characteristic of immunotherapeutics. In conclusion, PL might be of use in immunochemotherapy of cancer because of its effective activities on tumor growth and metastasis through the immunopotentiation of the patients without toxicity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10102797     DOI: 10.1016/s0162-3109(98)00063-0

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  44 in total

1.  Prevention of intraperitoneal adhesions and abscesses by polysaccharides isolated from Phellinus spp in a rat peritonitis model.

Authors:  Jae-Sung Bae; So-Jeo Ahn; Hyunee Yim; Kwang-Ho Jang; Hee Kyung Jin
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

2.  Pro-inflammatory macrophage polarization enhances the anti-cancer efficacy of self-assembled galactomannan nanoparticles entrapped with hydrazinocurcumin.

Authors:  Manisha Kumari; Mahaveer P Purohit; Richa Pahuja; Satyakam Patnaik; Yogeshwer Shukla; Pradeep Kumar; Kailash C Gupta
Journal:  Drug Deliv Transl Res       Date:  2019-12       Impact factor: 4.617

3.  Antitumor and immunomodulatory effects of weikangfu granule compound in tumor-bearing mice.

Authors:  Xiaohua Nie; Baojun Shi; Yuting Ding; Wenyi Tao
Journal:  Curr Ther Res Clin Exp       Date:  2006-03

4.  Medicinal mushroom Phellinus linteus as an alternative cancer therapy.

Authors:  Daniel Sliva
Journal:  Exp Ther Med       Date:  2010-05-01       Impact factor: 2.447

5.  Comparison of intraperitoneal anti-adhesive polysaccharides derived from Phellinus mushrooms in a rat peritonitis model.

Authors:  Jae-Sung Bae; Kwang-Ho Jang; Hee-Kyung Jin
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

6.  A case of spontaneous regression of hepatocellular carcinoma with multiple lung metastases.

Authors:  Hiroyuki Kojima; Noboru Tanigawa; Shuji Kariya; Atsushi Komemushi; Yuzo Shomura; Satoshi Sawada; Eitatsu Arai; Yoshiro Yokota
Journal:  Radiat Med       Date:  2006-02

7.  Inhibitory effects of polysaccharides isolated from Phellinus gilvus on benzo(a)pyrene-induced forestomach carcinogenesis in mice.

Authors:  Jae-Sung Bae; Kwang-Ho Jang; Hyunee Yim; Seung-Chun Park; Hee-Kyung Jin
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

8.  Phellinus linteus extract sensitizes advanced prostate cancer cells to apoptosis in athymic nude mice.

Authors:  Takanori Tsuji; Wei Du; Takashi Nishioka; Lihua Chen; Daisuke Yamamoto; Chang Yan Chen
Journal:  PLoS One       Date:  2010-03-31       Impact factor: 3.240

9.  Oyster (Crassostrea gigas) hydrolysates produced on a plant scale have antitumor activity and immunostimulating effects in BALB/c mice.

Authors:  Yu-Kai Wang; Hai-Lun He; Guo-Fan Wang; Hao Wu; Bai-Cheng Zhou; Xiu-Lan Chen; Yu-Zhong Zhang
Journal:  Mar Drugs       Date:  2010-02-02       Impact factor: 5.118

10.  Identification of Inonotus obliquus and analysis of antioxidation and antitumor activities of polysaccharides.

Authors:  Yana Song; Jing Hui; Wei Kou; Ru Xin; Fei Jia; Ning Wang; Fengqing Hu; Huili Zhang; Hongsheng Liu
Journal:  Curr Microbiol       Date:  2008-09-16       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.